AskTheDate.com
Back to calendar

Denali Therapeutics Inc. (DNLI) Earnings

DNLI reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.37
Actual EPS: $-0.68
EPS surprise: -32.54%
Company overview
Market Cap$4.0B
PriceUSD 24.83
EPS (TTM)-2.84
52-week high27.30
52-week low12.58
SectorHealth Technology
IndustryBiotechnology
Employees503